Halozyme Therapeutics Inc.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2009 | $13.7M | $-58.5M | $-58.4M |
| FY2010 | $13.6M | $-54.3M | $-53.2M |
| FY2011 | $56.1M | $-19.8M | $-19.8M |
| FY2012 | $42.3M | $-53.6M | $-53.6M |
| FY2013 | $54.8M | $-80.4M | $-83.5M |
| FY2014 | $75.3M | $-63.0M | $-68.4M |
| FY2015 | $135.1M | $-27.5M | $-32.2M |
| FY2016 | $146.7M | $-83.2M | $-103.0M |
| FY2017 | $316.6M | $81.0M | $63.0M |
| FY2018 | $151.9M | $-69.3M | $-80.3M |
| FY2019 | $196.0M | $-67.6M | $-72.2M |
| FY2020 | $267.6M | $144.3M | $129.1M |
| FY2021 | $443.3M | $275.9M | $402.7M |
| FY2022 | $660.1M | $267.5M | $202.1M |
| FY2023 | $829.3M | $337.6M | $281.6M |
| FY2024 | $1.02B | $551.5M | $444.1M |
| FY2025 | $1.40B | $469.0M | $316.9M |